{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:13:16Z","timestamp":1791083596227,"version":"4.1.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2,1]]},"DOI":"10.1093\/cvr\/cvp335","type":"journal-article","created":{"date-parts":[[2009,10,9]],"date-time":"2009-10-09T00:25:39Z","timestamp":1255047939000},"page":"444-453","source":"Crossref","is-referenced-by-count":75,"title":["Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers\u2020"],"prefix":"10.1093","volume":"85","author":[{"given":"Natee","family":"Jearawiriyapaisarn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong M.","family":"Moulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sazani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Kole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monte S.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,10,8]]},"reference":[{"key":"key\n\t\t\t\t20170518142415_CVP335C1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0888-7543(88)90113-9","article-title":"An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus","volume":"2","author":"Monaco","year":"1988","journal-title":"Genomics"},{"key":"key\n\t\t\t\t20170518142415_CVP335C2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/oli.2008.0161","article-title":"Therapeutic potential of splice-switching oligonucleotides","volume":"19","author":"Bauman","year":"2009","journal-title":"Oligonucleotides"},{"key":"key\n\t\t\t\t20170518142415_CVP335C3","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1056\/NEJMoa073108","article-title":"Local dystrophin restoration with antisense oligonucleotide PRO051","volume":"357","author":"van Deutekom","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518142415_CVP335C4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/hmg\/7.7.1083","article-title":"Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides","volume":"7","author":"Dunckley","year":"1998","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170518142415_CVP335C5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0960-8966(99)00010-3","article-title":"Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides","volume":"9","author":"Wilton","year":"1999","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20170518142415_CVP335C6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1073\/pnas.98.1.42","article-title":"Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse","volume":"98","author":"Mann","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170518142415_CVP335C7","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm897","article-title":"Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse","volume":"9","author":"Lu","year":"2003","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170518142415_CVP335C8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1073\/pnas.0406700102","article-title":"Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles","volume":"102","author":"Lu","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170518142415_CVP335C9","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/hmg\/ddg196","article-title":"Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle","volume":"12","author":"Gebski","year":"2003","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170518142415_CVP335C10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jgm.838","article-title":"Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide","volume":"8","author":"Fletcher","year":"2006","journal-title":"J Gene Med"},{"key":"key\n\t\t\t\t20170518142415_CVP335C11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm1345","article-title":"Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology","volume":"12","author":"Alter","year":"2006","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170518142415_CVP335C12","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/sj.mt.6300245","article-title":"Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse","volume":"15","author":"Fletcher","year":"2007","journal-title":"Mol Ther"},{"key":"key\n\t\t\t\t20170518142415_CVP335C13","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/sj.gt.3302877","article-title":"Gene therapy progress and prospects: Duchenne muscular dystrophy","volume":"13","author":"Foster","year":"2006","journal-title":"Gene Ther"},{"key":"key\n\t\t\t\t20170518142415_CVP335C14","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/mt.2008.120","article-title":"Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice","volume":"16","author":"Jearawiriyapaisarn","year":"2008","journal-title":"Mol Ther"},{"key":"key\n\t\t\t\t20170518142415_CVP335C15","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1093\/nar\/gkm478","article-title":"Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity","volume":"35","author":"Wu","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170518142415_CVP335C16","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1056\/NEJMe0707795","article-title":"Skipping toward personalized molecular medicine","volume":"357","author":"Hoffman","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518142415_CVP335C17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0960-8966(95)00001-4","article-title":"How does dystrophin deficiency lead to muscle degeneration?\u2013evidence from the mdx mouse","volume":"5","author":"McArdle","year":"1995","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20170518142415_CVP335C18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.nmd.2004.04.007","article-title":"Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings","volume":"14","author":"Quinlan","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20170518142415_CVP335C19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.nmd.2007.01.011","article-title":"Myostatin does not regulate cardiac hypertrophy or fibrosis","volume":"17","author":"Cohn","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"key\n\t\t\t\t20170518142415_CVP335C20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/eurheartj\/ehn406","article-title":"Long-term blinded placebo-controlled study of SNT-MC17\/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance","volume":"31","author":"Buyse","year":"2008","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170518142415_CVP335C21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.echo.2006.02.003","article-title":"Abnormalities of diastolic function precede dilated cardiomyopathy associated with Duchenne muscular dystrophy","volume":"19","author":"Markham","year":"2006","journal-title":"J Am Soc Echocardiogr"},{"key":"key\n\t\t\t\t20170518142415_CVP335C22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1096\/fj.04-1731fje","article-title":"Dystrophin- and MLP-deficient mouse hearts: marked differences in morphology and function, but similar accumulation of cytoskeletal proteins","volume":"19","author":"Wilding","year":"2005","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20170518142415_CVP335C23","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0894-7317(05)80373-6","article-title":"Echocardiographic and cardiac Doppler assessment of mice","volume":"8","author":"Pollick","year":"1995","journal-title":"J Am Soc Echocardiogr"},{"key":"key\n\t\t\t\t20170518142415_CVP335C24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1042\/BST0350775","article-title":"Cell-penetrating-peptide-based delivery of oligonucleotides: an overview","volume":"35","author":"Abes","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"key\n\t\t\t\t20170518142415_CVP335C25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.addr.2007.09.002","article-title":"Cell penetrating peptide conjugates of steric block oligonucleotides","volume":"60","author":"Lebleu","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"key\n\t\t\t\t20170518142415_CVP335C26","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/mt.2008.52","article-title":"Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle","volume":"16","author":"Townsend","year":"2008","journal-title":"Mol Ther"},{"key":"key\n\t\t\t\t20170518142415_CVP335C27","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/01.CIR.0000089371.11664.27","article-title":"Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart","volume":"108","author":"Yue","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170518142415_CVP335C28","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1073\/pnas.0508917103","article-title":"Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model","volume":"103","author":"Denti","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170518142415_CVP335C29","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/sj.mt.6300144","article-title":"Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure","volume":"15","author":"Townsend","year":"2007","journal-title":"Mol Ther"},{"key":"key\n\t\t\t\t20170518142415_CVP335C30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1089\/hum.2008.058","article-title":"Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice","volume":"19","author":"Bostick","year":"2008","journal-title":"Hum Gene Ther"},{"key":"key\n\t\t\t\t20170518142415_CVP335C31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/hum.2008.012","article-title":"Long-term benefit of adeno-associated virus\/antisense-mediated exon skipping in dystrophic mice","volume":"19","author":"Denti","year":"2008","journal-title":"Hum Gene Ther"},{"key":"key\n\t\t\t\t20170518142415_CVP335C32","doi-asserted-by":"crossref","first-page":"14814","DOI":"10.1073\/pnas.0805676105","article-title":"Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer","volume":"105","author":"Wu","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170518142415_CVP335C33","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJM198805263182104","article-title":"Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy","volume":"318","author":"Hoffman","year":"1988","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170518142415_CVP335C34","first-page":"54","article-title":"Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies","volume":"49","author":"Beggs","year":"1991","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t20170518142415_CVP335C35","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1016\/j.yjmcc.2007.03.429","article-title":"Dystrophin deficient MDX mice poorly tolerate dobutamine stress","volume":"42","author":"Van der Mieren","year":"2007","journal-title":"J Mol Cell Card"},{"key":"key\n\t\t\t\t20170518142415_CVP335C36","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ahj.2008.01.018","article-title":"Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry","volume":"155","author":"Connuck","year":"2008","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170518142415_CVP335C37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/humu.20918","article-title":"Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations","volume":"30","author":"Aartsma-Rus","year":"2009","journal-title":"Hum Mutat"},{"key":"key\n\t\t\t\t20170518142415_CVP335C38","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0070-2153(08)00609-1","article-title":"The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies","volume":"84","author":"Banks","year":"2008","journal-title":"Curr Top Dev Biol"},{"key":"key\n\t\t\t\t20170518142415_CVP335C39","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00335-007-9037-1","article-title":"Understanding hereditary diseases using the dog and human as companion model systems","volume":"18","author":"Tsai","year":"2007","journal-title":"Mamm Genome"},{"key":"key\n\t\t\t\t20170518142415_CVP335C40","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/ncpcardio1110","article-title":"Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression","volume":"5","author":"Keren","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"key\n\t\t\t\t20170518142415_CVP335C41","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/mt.2008.157","article-title":"Peptide-conjugated antisense therapy takes a skip ahead","volume":"16","author":"Wells","year":"2008","journal-title":"Mol Ther"},{"key":"key\n\t\t\t\t20170518142415_CVP335C42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","article-title":"The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy","volume":"26","author":"Nigro","year":"1990","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20170518142415_CVP335C43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000068446","article-title":"The heart in human dystrophinopathies","volume":"99","author":"Finsterer","year":"2003","journal-title":"Cardiology"},{"key":"key\n\t\t\t\t20170518142415_CVP335C44","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s004150050163","article-title":"Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period","volume":"244","author":"Hoogerwaard","year":"1997","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20170518142415_CVP335C45","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/0735-1097(93)90781-U","article-title":"Cardiac involvement in Becker muscular dystrophy","volume":"22","author":"Melacini","year":"1993","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/85\/3\/444\/17199331\/cvp335.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T02:26:26Z","timestamp":1558578386000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-lookup\/doi\/10.1093\/cvr\/cvp335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,8]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,10,8]]},"published-print":{"date-parts":[[2010,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvp335","relation":{},"ISSN":["1755-3245","0008-6363"],"issn-type":[{"value":"1755-3245","type":"electronic"},{"value":"0008-6363","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10,8]]}}}